IM Cannabis Corp. (IMCC)
NASDAQ: IMCC · Real-Time Price · USD
0.2320
-0.0110 (-4.53%)
At close: May 15, 2026, 4:00 PM EDT
0.2340
+0.0020 (0.86%)
After-hours: May 15, 2026, 7:21 PM EDT
IM Cannabis Revenue
IM Cannabis had revenue of 8.68M CAD in the quarter ending March 31, 2026, a decrease of -30.57%. This brings the company's revenue in the last twelve months to 50.91M, down -6.53% year-over-year. In the year 2025, IM Cannabis had annual revenue of 54.73M with 1.30% growth.
Revenue (ttm)
50.91M CAD
Revenue Growth
-6.53%
P/S Ratio
0.04
Revenue / Employee
1,157,045 CAD
Employees
44
Market Cap
1.44M USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 54.73M | 700.00K | 1.30% |
| Dec 31, 2024 | 54.03M | 5.23M | 10.71% |
| Dec 31, 2023 | 48.80M | -5.53M | -10.18% |
| Dec 31, 2022 | 54.34M | 20.28M | 59.56% |
| Dec 31, 2021 | 34.05M | 18.16M | 114.30% |
| Dec 31, 2020 | 15.89M | 6.82M | 75.12% |
| Dec 31, 2019 | 9.07M | 3.88M | 74.60% |
| Dec 31, 2018 | 5.20M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Biofrontera | 43.20M |
| Sunshine Biopharma | 35.49M |
| cbdMD | 19.98M |
| Universe Pharmaceuticals INC | 17.86M |
| Sonoma Pharmaceuticals | 17.72M |
| InMed Pharmaceuticals | 4.94M |
| China SXT Pharmaceuticals | 1.54M |
| RedHill Biopharma | 286.00K |
IMCC News
- 3 days ago - IM Cannabis Corp. Announces First Quarter 2026 Financial Results - PRNewsWire
- 9 days ago - IM Cannabis Raised US$550,000 of Gross Proceeds in Convertible Note Financings - PRNewsWire
- 5 weeks ago - IMC Announces Receipt of Nasdaq Minimum Bid Price Notification - PRNewsWire
- 6 weeks ago - IM Cannabis Reports 2025 Results: Revenue of C$54.7 Million with Over 134% Growth in Germany and Positive Operating Cash Flow - PRNewsWire
- 2 months ago - Avant Brands issues notice of termination for agreement with Adjupharm - TheFly
- 2 months ago - IM Cannabis enters non-binding LOI to acquire 51% of Blackaxe Technologies - TheFly
- 2 months ago - IMC Announces a Strategic Entry to the Cyber Drone Interception and Satellite Intelligence Markets by Signing a Non-Binding Agreement to Acquire 51% of Blackaxe Technologies - PRNewsWire
- 3 months ago - IM Cannabis files to sell 9.79M common shares for holders - TheFly